N@N

ArthroCare Announces Second Quarter 2010 Financial Results Press Release and Conference Call Dates

^{Published on 2010-07-30 14:30:48 - Market Wire}
 

AUSTIN, Texas--([ BUSINESS WIRE ])--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today its plan to announce second quarter 2010 results on Wednesday, August 4, 2010.

ArthroCare plans to issue a press release for the second quarter 2010 after the market closes on Tuesday, August 3, 2010, and will host a conference call on Wednesday, August 4, 2010, at 8:30 a.m. ET/5:30 a.m. PT to review the results. To participate in the live conference call dial 800-785-6380. A live and on-demand Web cast of the call will be available on ArthroCarea™s Web site at [ www.arthrocare.com ]. A telephonic replay of the conference call can be accessed by dialing 800-633-8284 and entering pass code number 21477843. The replay will remain available through August 17, 2010.

ABOUT ARTHROCARE

Founded in 1993, ArthroCare Corp. is a highly innovative, multi-business medical device company that develops, manufactures, and markets minimally invasive surgical products. With these products, ArthroCare targets a multi-billion dollar market across several medical specialties, significantly improving existing surgical procedures and enabling new, minimally invasive procedures. Many of ArthroCarea™s products are based on its patented Coblation® technology, which uses low-temperature radio frequency energy to gently and precisely dissolve rather than burn soft tissue a" minimizing damage to healthy tissue. Used in surgeries worldwide, Coblation-based devices have been developed and marketed for sports medicine; spine/neurologic; ear, nose and throat (ENT); cosmetic; urologic; and gynecologic procedures. ArthroCare also has added a number of other technologies to its portfolio, including Opus Medical sports medicine, Parallax spine and Applied Therapeutics ENT products, to complement Coblation within key indications.